Press Release
Aug 09, 2022
Contact: Chris Martin, IASLC Media Relations, cmartin@davidjamesgroup.com, 630.670.2745
What: The International Association for the Study of Lung Cancer (IASLC) 2022 World Conference on Lung Cancer Presidential Symposium Press Briefing
When: Monday, August 9, 2022, at 10:10 a.m. CEST
Where: For journalists covering the meeting onsite, the press briefings will be held in Room Location: Schubert 5-6, Upper Level, Congress Centre.
Zoom Link: For journalists covering the meeting remotely, the Zoom link for the press briefing is: https://us02web.zoom.us/j/82863561528
About: Each IASLC World Conference on Lung Cancer highlights the best in lung cancer research. Each press briefing will be moderated by an IASLC member and include an IASLC Patient Advocate, to provide a unique perspective on how research may affect patients coping with lung cancer.
Moderator: Dr. Brandon Stiles
Patient Advocate: Dusty Donaldson
Panelists:
- Abstract 2268: Evaluation of Outdoor Air Pollution in Female Non-Smoking Lung Cancer Patients -- Dr. Renelle Myers
- Abstract 1220: Association Between KRAS/STK11/KEAP1 Mutations and Outcomes in POSEIDON: Durvalumab ± Tremelimumab + Chemotherapy in mNSCLC (POSEIDON cohort was reported in a recent WCLC)—Dr. Solange Peters
- Abstract 1324: Sexual Health Assessment in Women with Lung Cancer (SHAWL) Study –Dr. Narjust Florez
- Abstract 240: Initial Steps in Creating a Patient-centric Addendum to clinical Trial Informed Consent Forms—Dr. Belinda King Kallimanis
- Abstract 1849: First Line Pembrolizumab or Placebo Combined with Etoposide and Platinum for ES-SCLC: KEYNOTE-604 Long-Term Follow-Up Results-- Dr. Charles Rudin
Recordings of the press briefings will be sent after the briefing concludes.
Embargoes: abstracts that are part of the press program will be embargoed for beginning of each day’s press briefing. The IASLC reserves the right to change an embargo to account for a journal publication or other issues.
Media Registration: If you have not registered to cover the meeting, visit https://wclc2022.iaslc.org/press-media/.
# # #
About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes nearly 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.
About the WCLC:
The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies, attracting more than 7,000 researchers, physicians and specialists from more than 100 countries. The goal is to increase awareness, collaboration and understanding of lung cancer, and to help participants implement the latest developments across the globe. The conference will cover a wide range of disciplines and unveil several research studies and clinical trial results. For more information, visit https://wclc2022.iaslc.org/